Thromboprophylaxis
Showing 26 - 50 of 334
Esophageal Tumors, Thrombosis, Thromboembolism Trial in Aarhus N (Fragmin 5000 UNT in 0.2 ML Prefilled Syringe)
Recruiting
- Esophageal Neoplasms
- +2 more
- Fragmin 5000 UNT in 0.2 ML Prefilled Syringe
-
Aarhus N, DenmarkThrombosis and Haemostasis Research Unit, Department for Clinica
Sep 23, 2021
Sickle Cell Disease, Central Venous Catheter Thrombosis, Venous Thromboembolism Trial (Rivaroxaban 10 MG, Placebo)
Not yet recruiting
- Sickle Cell Disease
- +2 more
- Rivaroxaban 10 MG
- Placebo
- (no location specified)
Sep 27, 2021
Critical Illness Trial (Nadroparin (intravenous Infusion), Nadroparin (subcutaneous group))
Completed
- Critical Illness
- Nadroparin (intravenous Infusion)
- Nadroparin (subcutaneous group)
- (no location specified)
Jul 19, 2021
Thrombopenia, Covid19 Trial (EP-7041 Injection)
Not yet recruiting
- Thrombopenia
- Covid19
- EP-7041 Injection
- (no location specified)
Sep 10, 2021
Multiple Myeloma in Relapse, Multiple Myeloma Progression, Multiple Myeloma Stage II Trial in London (Rivaroxaban, ASA)
Recruiting
- Multiple Myeloma in Relapse
- +5 more
-
London, Ontario, CanadaLondon Health Sciences Centre
Oct 3, 2022
Venous Thromboembolism After Incisional Ventral Hernia Repair.
Completed
- Incisional Hernia
- Venous Thromboembolism
- hernia repair
-
Moscow, Russian FederationPirogov Russian National Research Medical University
Jun 27, 2022
Medical Patient, Thrombocytopenia Trial in Chieti (Fondaparinux)
Terminated
- Medical Patient
- Thrombocytopenia
-
Chieti, ItalyMarcello Di Nisio
Jul 14, 2021
Venous Thromboembolic Disease, Pulmonary Embolism, Venous Thromboembolism Trial (The multifaceted interventions, Routine VTE
Recruiting
- Venous Thromboembolic Disease
- +4 more
- The multifaceted interventions
- Routine VTE prophylaxis
-
Beijing, Beijing, ChinaChina-Japan Friendship Hospital
Jan 19, 2023
Covid19 Trial in Milano (Enoxaparin)
Completed
- Covid19
-
Milano, ItalyAzienda Socio Sanitaria Territoriale Grande Ospedale Metropolita
Jun 7, 2021
Thrombosis Trial in Worldwide (Rivaroxaban, Acetylsalicylic Acid)
Hematological Patients, Newly Diagnosed Multiple Myeloma, Chemo Trial in Lyon, Saint-Étienne (Blood samples)
Not yet recruiting
- Hematological Patients
- +2 more
- Blood samples
-
Lyon, France
- +1 more
Feb 17, 2022
Heparins for Thromboprophylaxis in COVID-19 Patients: HETHICO
Completed
- COVID-19
- Hypercoagulability
- Low Molecular Weight Heparin
-
Padova, ItalyGiuseppe Camporese
Mar 17, 2021
Thrombophilia Associated With Pregnancy, Perioperative/Postoperative Complications, Venous Thrombosis Trial in Sao Paulo
Completed
- Thrombophilia Associated With Pregnancy
- +5 more
- Enoxaparin
- No intervention
-
Sao Paulo, BrazilUniversity of Sao Paulo General Hospital
Apr 27, 2021
Deep Vein Thrombosis Trial in Istanbul (Duplex Ultrasound)
Completed
- Deep Vein Thrombosis
- Duplex Ultrasound
-
Istanbul, Kadikoy, TurkeyIstanbul Medeniyet University
Jan 13, 2021
Severe Bleeding in COVID-19 Patients Treated With Higher Than
Completed
- COVID-19
-
Badalona, Barcelona, SpainManuel Monreal
Dec 11, 2020
Cancer, Rivaroxaban, Venous Thromboembolism Trial in Santo André (Rivaroxaban, Enoxaparin)
Recruiting
- Cancer
- +3 more
-
Santo André, São Paulo, BrazilScience Valley Research Institute
Aug 3, 2021
Thromboprophylaxis for Patients in ICU With COVID-19
Completed
- Covid19
- +2 more
-
Zaragoza, Aragón, Spain
- +30 more
Mar 29, 2022
Frequency of Vascular Events With Short-term Thromboprophylaxis
Completed
- Thromboembolic Events
- Post-operative Bleeding
-
Aarhus, Judland, Denmark
- +5 more
Jan 25, 2021
Dosing of Thromboprophylaxis and Mortality in Critically Ill
Completed
- Covid19
- Thromboembolism
- Dose of tinzaparin or dalteparin
-
Stockholm, SwedenSödersjukhuset
Oct 18, 2020
Thromboprophylaxis In Burn Care Patients
Completed
- Skin Burn Extensive
-
Montreal, Quebec, CanadaCentre hospitalier de l'Université de Montréal (CHUM)
Jul 30, 2020
Venous Thromboembolism, Pulmonary Embolism, Thromboprophylaxis Trial in Tampere (Enoxaparin)
Recruiting
- Venous Thromboembolism
- +2 more
-
Tampere, Pirkanmaa, FinlandTampere University Hospital
Feb 25, 2021
VTE and Higher Hypercoagulability in Patients Recovered in ICU
Completed
- COVID-19 Disease
- Thromboembolism, Venous
- thromboprophylaxis with low-molecular-weight heparin or fondaparinux
-
Padova, ItalyGiuseppe Camporese
Sep 15, 2020